Alvotech (ALVO) Amortization of Deferred Charges (2021 - 2026)
Alvotech's (ALVO) quarterly Amortization of Deferred Charges came in at $41.0 million in Q2 2026, up 11.93% on a YoY basis from $36.7 million in Q2 2025, and up 0.53% quarter-over-quarter from $40.8 million in Q1 2026.
Analysis
Alvotech (ALVO) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Amortization of Deferred Charges for 6 consecutive years, with $41.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Amortization of Deferred Charges rose 11.93% year-over-year to $41.0 million; the trailing twelve-month figure through Jun 2026 stood at $158.8 million (up 62.17% YoY), and the FY2025 full-year result was $149.2 million, down 50.79% from the prior year.
- Amortization of Deferred Charges rose to $41.0 million in Q2 2026 per ALVO's latest filing, from $40.8 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $184.1 million in Q1 2024 and bottomed at -$143.3 million in Q2 2023.
- Historically, Amortization of Deferred Charges has averaged $50.1 million across 5 years, with a median of $40.9 million in 2026.
- The sharpest annual moves came in 2023 and 2025: Amortization of Deferred Charges sank 541.36% in 2023, then jumped 516.53% in 2025.
- Over 5 years, Amortization of Deferred Charges stood at $119.2 million in 2022, then soared by 33.65% to $159.3 million in 2023, then sank by 58.9% to $65.5 million in 2024, then sank by 235.14% to -$88.5 million in 2025, then jumped by 146.36% to $41.0 million in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $41.0 million, $40.8 million, and -$88.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.02 Mn |
| Mar 31, 2026 | 40.81 Mn |
| Dec 31, 2025 | -88.49 Mn |
| Sep 30, 2025 | 165.49 Mn |
| Jun 30, 2025 | 36.65 Mn |
| Mar 31, 2025 | 35.54 Mn |
| Dec 31, 2024 | 65.48 Mn |
| Sep 30, 2024 | -39.73 Mn |
| Jun 30, 2024 | 93.35 Mn |
| Mar 31, 2024 | 184.06 Mn |
| Dec 31, 2023 | 159.33 Mn |
| Jun 30, 2023 | -143.30 Mn |
| Dec 31, 2022 | 119.22 Mn |
| Jun 30, 2022 | 32.47 Mn |
| Dec 31, 2021 | -39.99 Mn |
| Sep 30, 2021 | 33.78 Mn |